<!DOCTYPE HTML>
<html>
  <head>
    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
    <meta http-equiv="Content-type" content="text/html; charset=utf-8">
	<title>Imipramine</title>
	</head>
  <body onLoad="init();">
    <div data-role="page" data-theme="b">
  	<div data-role="header" data-theme="b" data-position="fixed">
    	<h1>Imipramine</h1> 
    	<a href="#" data-rel="back" data-icon="arrow-l" data-theme="b" data-direction="reverse" >Back</a>
	</div>
    <div data-role="content">
<h3>Brand name: Tofranil</h3>
<hr>
					<h3>Adult Starting Dose (Max Per Day)</h3>	
					<ul>
						<li>Initial adult dose = 25mg QD to QID </li>
						<li>Max adult dose/day = 300mg </li>
						<li>Initial geriatric dose = 10mg-25mg Qhs</li>
					</ul>
<hr>
					<h3>Advantages</h3>	
					<ul>
						<li>Consider using to ameliorate the symptoms of Acute Stress Disorder (ASD) </li>
						<li>Consider using for hyperarousal, excessive arousal and panic attacks for up to 7 days </li>
						<li>Therapeutic plasma concentrations can be used to guide treatment </li>
						<li>Therapeutic levels for depression (in conjunction with psychiatry consultation): 200-350 ng/ml </li>
						<li>Generic</li>
					</ul>
<hr>
					<h3>Disadvantages</h3>	
					<ul>
						<li><b>Contraindications include acute recovery phase following MI</b> </li>
						<li>Adverse Side Effects: cardiovascular (orthostatic hypotension, syncope, tachycardia, arrhythmias), anticholinergic (constipation, dry mouth, blurred vision, urinary retention, increased intraocular pressure), sedation, weight gain, sexual dysfunction, and decreased seizure threshold</li>
					</ul>
<hr>
					<h3>Pregnancy Category</h3>	
					<ul>
							<li>Positive evidence of risk; However potential benefits may outweigh potential risks</li>	
					</ul>
<hr>
					<h3>Safety Margin for TCAs</h3>	
					<ul>
						<li>Lethal in OD </li>
						<li>Contraindicated with MAOIs within past 14 days of therapy </li>
						<li>Bupropion, Haloperidol and SSRIs may increase the TCA's level which may increase pharmacologic and adverse effects. Wait 5 weeks after discontinuing fluoxetine before starting a TCA</li> 
						<li>Quinolones (Gatifloxacin, Moxifloxacin) if used with TCA's may cause QT prolongation and may increase the risk of life-threatening cardiac arrhythmias </li>
						<li>Quinolones (Grepafloxacin, Sparfloxacin) if used with TCAs have an increased risk of lifethreatening arrhythmias including torsades de pointes</li>
						<li>Contraindicated use with desipramine and thioridazine </li>
						<li>Slow system clearance</li>
						<li>Avoid concomitant use with clonidine, levodopa, Quinolones, guanethidine, alcohol, valerian, st. john's wort, kava kava, nilotinib, sibutramine, tetrabenazine, thioridazine and ziprasidone</li> 
					</ul>
<hr>
					<h3>Efficacy for TCAs</h3>	
					<ul>
						<li>Response rate = mild depression 4-8 weeks; Moderate depression = 8-12 week; Severe depression = augmentative strategies, concurrent administration of adjuncts (referral to specialist)</li>
						<li>Recommended as monotherapy as secondline therapy in PTSD </li>
						<li>Amitriptyline has fair documentation for efficacy in use for fibromyalgia </li>
						<li>Good evidence exists from multiple well-designed clinical trials that amitriptyline has medium to high efficacy in the prevention of migraines</li>	
						<li>Doses typically are lower for migraine treatment than for depression treatment </li>
						<li>Nortriptyline has been used in clinical studies for smoking cessation</li>
						<li>TCAs are considered to be the drug of choice by some clinicians for symptomatic relief of neuropathic pain (postherpetic neuralgia)</li> 
						<li>Doxepin is approved for use in anxiety associated with alcoholism</li>		
					</ul>
<hr>
<a href="../adverse_effects.html" data-role="button">Adverse Effects</a>



    </div><!-- end jqm content -->
   
    </div><!-- end jqm page -->
  </body>
</html>
